SCHEMBL21748783

SCHEMBL21748783

O=C(O)N1CC/C(=N\O)C(c2ccccc2)C1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 1/20 0.39
TSHR P16473 1/20 0.39
KIF11 P52732 6/20 0.38
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
ATM Q13315 1/20 0.36
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
POLB P06746 2/20 0.35
TP53 P04637 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CHRNA7 P36544 1/20 0.35
HPGD P15428 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4481228 0.82 USP30 (0.46) KDM4E
SCHEMBL21773364 0.82 USP30 (0.46) KDM4E
SCHEMBL16392349 0.71 ALDH1A1 (0.44) ALDH1A1LMNAMAPTL3MBTL1KDM4E
SCHEMBL4608020 0.68 ALDH1A1 (0.53) ALDH1A1LMNAMAPTL3MBTL1KDM4E
SCHEMBL4608025 0.68 ALDH1A1 (0.53) ALDH1A1LMNAMAPTL3MBTL1KDM4E
SCHEMBL3183827 0.67 RAB9A (0.67) ALDH1A1LMNAMAPTL3MBTL1TSHR
SCHEMBL1201854 0.67 ALDH1A1 (0.59) ALDH1A1LMNAMAPTL3MBTL1KDM4E
SCHEMBL3183837 0.67 RAB9A (0.67) ALDH1A1LMNAMAPTL3MBTL1TSHR
SCHEMBL15874872 0.67 ALDH1A1 (0.59) ALDH1A1LMNAMAPTL3MBTL1KDM4E
SCHEMBL1201856 0.67 ALDH1A1 (0.59) ALDH1A1LMNAMAPTL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12005054-B2 Piperidinyl-3-(aryloxy)propanamides and propanoates TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-06-11 US disclosed
CN-112236423-B Piperidinyl-3- (aryloxy) propanamides and propionic acid esters 武田药品工业株式会社 2024-02-06 CN disclosed
US-20230021834-A1 PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-01-26 US disclosed
US-11045457-B2 Piperidinyl-3-(aryloxy)propanamides and propanoates TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2021-06-29 US disclosed
US-20200061041-A1 PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2020-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11045457-B2 Piperidinyl-3-(aryloxy)propanamides and propanoates SSTR4, SSTR3, NPY4R ALDH1A1 1476/4885LMNA 2601/4885MAPT 4500/4885
US-12005054-B2 Piperidinyl-3-(aryloxy)propanamides and propanoates SSTR4, SSTR3, NPY4R ALDH1A1 1476/4885LMNA 2601/4885MAPT 4500/4885
US-20200061041-A1 PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES SSTR4, SSTR3, NPY4R ALDH1A1 1476/4885LMNA 2601/4885MAPT 4500/4885
US-20230021834-A1 PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES SSTR4, SSTR3, NPY4R ALDH1A1 1476/4885LMNA 2601/4885MAPT 4500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.